Stay updated on Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page.

Latest updates to the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1, indicating a minor page update with no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check47 days agoChange DetectedMinor UI and metadata updates: Show glossary feature was added; capitalization adjustments to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act data'; and the site revision updated to v3.4.0 (replacing the previous v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a Locations section with Rhode Island as a study site and replaced the Rhode Island Locations heading. The page revision is updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page.